According to Agenus 's latest financial reports the company's total assets are $0.31 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.31 B | -24.09% |
2022-12-31 | $0.41 B | -11.25% |
2021-12-31 | $0.46 B | 117.22% |
2020-12-31 | $0.21 B | 38.1% |
2019-12-31 | $0.15 B | 13.88% |
2018-12-31 | $0.13 B | -1.45% |
2017-12-31 | $0.13 B | -11.84% |
2016-12-31 | $0.15 B | -35.19% |
2015-12-31 | $0.24 B | 225.02% |
2014-12-31 | $74.52 M | 113.94% |
2013-12-31 | $34.83 M | 19.74% |
2012-12-31 | $29.09 M | 46.88% |
2011-12-31 | $19.8 M | -35.91% |
2010-12-31 | $30.9 M | -32.63% |
2009-12-31 | $45.87 M | -19.27% |
2008-12-31 | $56.82 M | 27.58% |
2007-12-31 | $44.53 M | -38.95% |
2006-12-31 | $72.95 M | -29.96% |
2005-12-31 | $0.10 B | -21.73% |
2004-12-31 | $0.13 B | -5.01% |
2003-12-31 | $0.14 B | 57.28% |
2002-12-31 | $89.06 M | -4.79% |
2001-12-31 | $93.54 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 53,277.21% | ๐บ๐ธ USA |
Merck MRK | $106.67 B | 33,882.35% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $95.15 B | 30,213.81% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $75.11 B | 23,828.09% | ๐ฌ๐ง UK |
Celldex Therapeutics CLDX | $0.46 B | 48.33% | ๐บ๐ธ USA |